IP Verse

Institut National De La Santé Et De La Recherche Médicale (inserm) opposition analysis

COMPANY ANALYSIS

Latest patents of Institut National De La Santé Et De La Recherche Médicale (inserm) opposed by its competitors

Patent:
EP3911354
Grant Date:
Apr 3, 2024
Title:
Aav-Mediated Gene Therapy Restoring The Otoferlin Gene
Oppositions:
4
Patent:
EP3920970
Grant Date:
Nov 23, 2022
Title:
Method For Treating Checkpoint Inhibitors Induced Adverse Events
Oppositions:
1
Patent:
EP3444271
Grant Date:
Oct 6, 2021
Title:
Il-15 And Il-15Raplha Sushi Domain Based Modulokines
Oppositions:
2
Patent:
EP3256573
Grant Date:
Dec 9, 2020
Title:
Recombinant Adeno-Associated Virus Particle Purification With Multiple-Step Anion Exchange Chromatography
Oppositions:
1
Patent:
EP2900820
Grant Date:
Nov 18, 2020
Title:
Methods For Producing A Population Of Pancreatic Beta-Cells
Oppositions:
1
Patent:
EP2909232
Grant Date:
Mar 11, 2020
Title:
Methods And Pharmaceutical Compositions For The Treatment Of Age-Related Macular Degeneration (Amd)
Oppositions:
1
Patent:
EP3030575
Grant Date:
Jul 11, 2018
Title:
Il-15 And Il-15Raplha Sushi Domain Based Modulokines
Oppositions:
1

Competitors of Institut National De La Santé Et De La Recherche Médicale (inserm)

DIAMYD MEDICAL AB

D YOUNG & CO LLP

HGF LIMITED

Want to track Institut National De La Santé Et De La Recherche Médicale (inserm)?

Feel free to send us a message here and we will get back to you